#USA #New York #Securities Fraud #Rosen Law Firm #Reckitt Benckiser

Important Securities Fraud Lawsuit for Reckitt Investors

On July 28, 2025, the Rosen Law Firm, known globally for protecting investor rights, urged purchasers of American Depositary Shares (ADSs) for Reckitt Benckiser Group PLC (OTC: RBGLY) to consider participating in a significant securities fraud lawsuit. This lawsuit pertains to individuals who bought Reckitt ADSs between January 13, 2021, and July 28, 2024, which is referred to as the "Class Period." The Rosen Law Firm has highlighted a crucial deadline of August 4, 2025, for those interested in becoming lead plaintiffs in this class action.

Who Should Join?

If you are among the investors who sustained losses exceeding $100,000 in Reckitt’s ADSs, you may have the opportunity to recuperate your losses without incurring any out-of-pocket fees. This is made possible through a contingency fee arrangement, meaning you only pay if you win. Investors are encouraged to join the ongoing class action and take advantage of their rights. For more details on how to participate, individuals can visit the Rosen Law Firm’s dedicated page at rosenlegal.com or get in touch with attorney Phillip Kim directly at 866-767-3653.

What’s At Stake?

The crux of the lawsuit lies in allegations against Reckitt Benckiser regarding their popular cow's milk-based formula, Enfamil. It has come to light that the company is allegedly responsible for failing to adequately warn investors and consumers about the risks associated with the consumption of this formula by preterm infants, particularly regarding the heightened risk of developing necrotizing enterocolitis (NEC). These oversights provided a materially false picture of Reckitt's operational health, potentially skewing positive statements regarding their business prospects and sales performance.

When the genuine circumstances emerged, the lawsuit asserts that investors faced significant financial damages due to these misleading claims. The legal proceedings to establish accountability and secure reparations for affected investors are already underway.

The Rosen Law Firm’s Advocacy

The Rosen Law Firm distinguishes itself by encouraging investors to select experienced legal counsel with a proven track record in securities litigation. Many companies that issue notices might lack the requisite expertise or commitment to litigate on behalf of their clients, merely acting as intermediaries. This is where the Rosen Law Firm stands apart, representing investors with a focus on achieving real results in class actions and shareholder derivative litigation.

Notably, the firm's history includes securing some of the largest settlement amounts in securities litigation, showcasing their determination and experience. Rosen Law Firm was recognized for having the most successful securities class action settlements in 2017, and since 2013, has consistently ranked among the top firms in this arena, recovering hundreds of millions for investors including a staggering $438 million in 2019.

Final Thoughts

The deadline for becoming a lead plaintiff in this significant action is approaching swiftly. Interested individuals should not hesitate to consult the Rosen Law Firm for guidance and support in the claim process. For those looking to reclaim their investments against Reckitt Benckiser for losses beyond $100,000, now is the time to act. Additionally, even without declaring themselves as lead plaintiffs, investors retain the right to share in any potential future recoveries.

For continuous updates, follow the Rosen Law Firm on their social media platforms including LinkedIn, Twitter, and Facebook.

Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Telephone: (212) 686-1060
Toll-Free: (866) 767-3653
Email: [email protected]
Website: rosenlegal.com